The 2023 Q3 earnings season kicks off tomorrow with major U.S. banks leading the way Despite the bleak backdrop, S&P 500's Q3 earnings outlook is not as bad as expected This...
U.S. jobs report, ISM PMI surveys, more earnings in focus. Apple shares are a buy with fiscal Q3 results due on Thursday. Pfizer’s stock is set to struggle amid shrinking...
Earnings season continues, with healthcare companies set to report next week Among them is Pfizer, whose stock has corrected significantly of late Based on the company's strong...
August is expected to be another volatile month on Wall Street amid a plethora of market-moving events. Investor focus will be on the U.S. jobs report, CPI inflation data, the...
Tech-savvy millennials are very active stock market participants At times, they tend to double the trading volume of older generations Using InvestingPro, let's take a look at some...
Moderna (NASDAQ:MRNA) shares closed lower on Tuesday after the vaccine maker said that its vaccine against seasonal flu did not achieve “early success” in the Phase 3...
Biotech company Moderna (NASDAQ:MRNA) is seeing its shares trade under pressure in recent days after the company reported last week Phase 3 trial results for its flu vaccine...
PCE inflation data, Fed FOMC minutes, retailer earnings in focus. Walmart stock is a buy amid strong results, upbeat guidance. Moderna shares set to underperform on big profit...
MRNA is an exceptionally difficult stock to value, given enormous uncertainty surrounding its COVID-19 vaccine and other drugs in its pipeline But there is a case that an...
The steep plunge in Moderna stock comes amid signs that the pandemic is moving towards an endemic stage The company still maintains a strong sales pipeline for its COVID vaccines,...
Hype stock. Trading pharma stocks is tedious at best, in this case, unrewarding too. I wouldn’t bother unless I heard news of a serious covid strain - the kind that sends crude oil down at least 10-15%.
0
What's up with Moderna today?
0
Told ya.
0
Sc mortgage should dump this
0
They have high conviction in this, they believe it offers the best growth story and new drugs in the works.